The U.S. Behind-the-Meter (BTM) market was valued at USD 2.50 billion in 2025 and is projected to reach USD 14.31 billion by 2035, growing at a CAGR of 19.2 % from 2026–2035. Growth is driven by ...

The emerging cancer therapy market, driven by breakthroughs like CAR-T cells and checkpoint inhibitors, offers significant growth opportunities. Companies advancing these technologies stand to benefit ...